Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
KIDS 
Orthopediatrics Corp (KIDS)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
11/05/2025: KIDS (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
7 Analysts rated it
Limited analyst coverage, niche firm, research info may be scarce.
1 Year Target Price $24.14
1 Year Target Price $24.14
| 3 | Strong Buy |
| 3 | Buy |
| 1 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -49.09% | Avg. Invested days 26 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 11/05/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 411.27M USD | Price to earnings Ratio - | 1Y Target Price 24.14 |
Price to earnings Ratio - | 1Y Target Price 24.14 | ||
Volume (30-day avg) 7 | Beta 1.07 | 52 Weeks Range 15.28 - 28.00 | Updated Date 11/6/2025 |
52 Weeks Range 15.28 - 28.00 | Updated Date 11/6/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -1.96 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2025-11-05 | When - | Estimate -0.2471 | Actual -0.24 |
Profitability
Profit Margin -20.06% | Operating Margin (TTM) -7.94% |
Management Effectiveness
Return on Assets (TTM) -4.08% | Return on Equity (TTM) -12.67% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 476588683 | Price to Sales(TTM) 1.81 |
Enterprise Value 476588683 | Price to Sales(TTM) 1.81 | ||
Enterprise Value to Revenue 2.16 | Enterprise Value to EBITDA -79.86 | Shares Outstanding 25077330 | Shares Floating 16875789 |
Shares Outstanding 25077330 | Shares Floating 16875789 | ||
Percent Insiders 32.7 | Percent Institutions 69.32 |
Upturn AI SWOT
Orthopediatrics Corp
Company Overview
History and Background
Orthopediatrics Corp. was founded in 2006 and focuses on providing orthopedic implants and instruments for children.
Core Business Areas
- Trauma and Deformity Correction: This segment develops and markets products for fracture fixation, limb lengthening, and correction of deformities in pediatric patients.
- Skeletal Reconstruction: Focuses on implants and instruments for reconstruction procedures, addressing conditions like scoliosis and hip dysplasia.
- Sports Medicine: Offers solutions for pediatric sports-related injuries, including ACL reconstruction and meniscal repair.
Leadership and Structure
The leadership team includes the CEO, CFO, and other executives overseeing different functional areas. The organizational structure is designed to support product development, sales, and marketing efforts focused on the pediatric orthopedic market.
Top Products and Market Share
Key Offerings
- Cannulated Blade System: A comprehensive system for femoral osteotomies. Competitors include DePuy Synthes and Stryker. Market share data not readily available.
- Response Scoliosis System: A scoliosis correction system designed for the unique anatomy of children. Competitors include Medtronic and NuVasive. Market share data not readily available.
- PediLoc Tibia Nailing System: A system for treating tibial fractures in pediatric patients. Competitors include DePuy Synthes and Stryker. Market share data not readily available.
Market Dynamics
Industry Overview
The pediatric orthopedic market is a specialized segment within the broader orthopedic industry, characterized by unique anatomical and physiological considerations for children. The market is growing due to increasing awareness of pediatric orthopedic conditions and technological advancements.
Positioning
Orthopediatrics Corp. is positioned as a leading provider of orthopedic implants and instruments specifically designed for children, differentiating itself from larger orthopedic companies that typically focus on adult patients. Their competitive advantage lies in their specialized expertise and product portfolio.
Total Addressable Market (TAM)
The global pediatric orthopedic market is estimated at several billion dollars, and is growing. Orthopediatrics focuses solely on this TAM.
Upturn SWOT Analysis
Strengths
- Specialized focus on pediatric orthopedics
- Proprietary product portfolio tailored for children
- Strong relationships with pediatric orthopedic surgeons
- Established distribution network
Weaknesses
- Smaller scale compared to larger orthopedic companies
- Limited financial resources for extensive R&D and marketing
- Dependence on a niche market
- Profitability challenges as the market matures
Opportunities
- Expanding product offerings to address unmet needs in pediatric orthopedics
- Increasing market penetration through strategic partnerships
- Geographic expansion into emerging markets
- Potential for acquisitions of complementary technologies or businesses
Threats
- Competition from larger orthopedic companies entering the pediatric market
- Regulatory changes affecting the approval and reimbursement of orthopedic devices
- Pricing pressures from hospitals and insurance companies
- Product liability risks associated with orthopedic implants
Competitors and Market Share
Key Competitors
- JNJ
- BSX
- MDT
- SYK
Competitive Landscape
Orthopediatrics competes with larger orthopedic companies that have broader product portfolios and greater financial resources. Orthopediatrics differentiates itself through its specialized focus on pediatric orthopedics and its proprietary product offerings.
Growth Trajectory and Initiatives
Historical Growth: Orthopediatrics Corp. has experienced revenue growth in recent years due to increased adoption of its products.
Future Projections: Analyst estimates project continued revenue growth for Orthopediatrics Corp. driven by expanding market penetration and product innovation.
Recent Initiatives: Recent initiatives include launching new products, expanding sales and marketing efforts, and pursuing strategic partnerships.
Summary
Orthopediatrics Corp. is a niche player in the pediatric orthopedic market, focusing on specialized implants and instruments. While the company benefits from its expertise and targeted product line, its smaller size and profitability challenges relative to larger competitors raise concerns. Strategic partnerships and geographic expansion are avenues for growth, while competition and regulatory changes pose ongoing threats.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Company SEC filings
- Industry reports
- Analyst estimates
Disclaimers:
This analysis is based on publicly available information and should not be considered financial advice. Market share estimates are approximate.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Orthopediatrics Corp
Exchange NASDAQ | Headquaters Warsaw, IN, United States | ||
IPO Launch date 2017-10-12 | President, CEO & Director Mr. David R. Bailey | ||
Sector Healthcare | Industry Medical Devices | Full time employees 562 | Website https://www.orthopediatrics.com |
Full time employees 562 | Website https://www.orthopediatrics.com | ||
OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity in children; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIRO Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, Mitchell Ponseti, and Boston Brace 3D. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.